Now a Virtual Experience: 2020 ISPE Continuous Manufacturing Virtual Workshop 

A New Decade for Continuous Manufacturing: Current Landscape & Future Opportunities 

Access Virtual Workshop

 


We continue to monitor the unfolding global impact of COVID-19, and as the world evolves, so do we. We are transforming this event to be fully digital: The 2020 ISPE Continuous Manufacturing Virtual Workshop.

You will still: 

  • Explore two tracks on continuous manufacturing for large molecules – drug substance, and continuous manufacturing for small molecules – drug product, drug substance, and API 
  • Identify the supply chain, safety, and quality assurance advantages provided by continuous manufacturing 
  • Learn about the different approaches to continuous manufacturing regarding equipment, measurement tools, and control strategies 
  • Analyze avenues for enhanced communication with regulators on innovative and emerging technologies 

It's our priority to make this the best and most informative 2020 ISPE Continuous Manufacturing Virtual Workshop to date, and we remain excited to host you in June. We will update the event page in the coming weeks with additional information.


Why Attend Virtually?

  • alt 1
    Feel like You're In-Person with a Fully Interactive Digital Experience
    Our event portal is easy to navigate and will allow you to view presentations, access PDFs of the presentations, take downloadable notes in each session, participate in polls, chat with other attendees, and participate in LIVE Q&A sessions with speakers.
  • alt 2
    Build Your Experience
    With access to 11+ sessions, add the sessions you want to attend with the click of a button to build your own custom agenda. Interested in two sessions happening at the same? We have you covered because you'll have access to all of the recordings from the event for one year.
  • alt 3
    Gain Actionable Insights
    Global experts will be at your fingertips as they share their knowledge and lessons learned on continuous manufacturing for large and small molecules including current status, emerging technologies, advances, potential for the future and much more.
  • alt  4
    Stay Current and Knowledgeable Throughout the Year
    In addition to expert insights, your tangible takeaways include access to the recording of ALL conference sessions and presentations for one year. Unlike an in-person event, you’ll get to experience the sessions you missed—that means both tracks! The recordings are also valuable as a refresher throughout the year.
  • alt  6
    Connect and Engage with Regulators, Industry Experts, and Your Peers
    You'll have opportunities to network with your fellow attendees and presenters just like you would at our in-person events. Engage throughout the day, during each session via the live chat, at the virtual reception, and during dedicated networking breaks and events.

Conference Highlights


Who Should Attend?

Engineers Engineering Managers & Directors OperationsProcess Engineers PAT SpecialistsValidation SpecialistsRegulatorsPlant Directors & ManagersProject Managers


Program Committee

Christine M. V. Moore, PhD
Global Head and Executive Director, GRACS CMC Policy
Merck & Co, Inc.
Chair and Board Ambassador
Gabriella Dahlgren, PhD
Manager, Strategy Deployment and Excellence, PQM
Janssen Supply Group LLC
Kelvin H. Lee, PhD
Director and Professor, Chemical & Biomolecular Engineering, Univ. of Delaware
NIIMBL
Michael K. O'Brien, PhD
Founder & President
NGT BioPharma Consultants
Jeffery N. Odum, CPIP
Head of Design, Technology & Standards, Biologics Engineering
Sanofi
Antonio R. Moreira, PhD
Vice Provost, Academic Affairs
University of Maryland, Baltimore County
Sharmista Chatterjee, PhD
Division Director
CDER, FDA
Malcolm B. Berry, PhD
Continuous Chemistry Team Manager
GlaxoSmithKline
Wyatt J. Roth, PhD
Senior Research Scientist
Eli Lilly & Co.
Placeholder Person Graphic
Matthew B. Shields
Head of Specialty Care Operations
Sanofi
Bernhardt L. Trout, Ph.D.
Professor, Chemical Engineering
MIT